0001781232-19-000002.txt : 20190701 0001781232-19-000002.hdr.sgml : 20190701 20190701162628 ACCESSION NUMBER: 0001781232-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 EFFECTIVENESS DATE: 20190701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellibre, Inc. CENTRAL INDEX KEY: 0001781232 IRS NUMBER: 831628741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-343242 FILM NUMBER: 19933520 BUSINESS ADDRESS: STREET 1: 10581 ROSELLE STREET STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 412-916-1516 MAIL ADDRESS: STREET 1: 10581 ROSELLE STREET STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001781232 Cellibre, Inc. 10581 ROSELLE STREET SUITE 100 SAN DIEGO CA CALIFORNIA 92121 412-916-1516 DELAWARE None None Corporation true 2017 Benjamin Chiarelli 7819 Camino De La Dora Rancho Santa Fe CA CALIFORNIA 92067 Executive Officer Biotechnology No Revenues 06b false 2019-06-21 false true true false 0 Paradigm Capital U.S., Inc. 104425 Paradigm Capital U.S., Inc. 104425 95 Wellington St. W. Suite 2101 Toronto A6 ONTARIO, CANADA M5J 2N7 NY NEW YORK TX TEXAS false 5000000 4188000 812000 Following initial closing on June 21, 2019, the Company withdrew offering, therefore, no amount remains to be sold. false 21 72000 0 Broker listed in Item 12 received a 6% commission on $1,200,000 sold to three (3) investors. 0 false Cellibre, Inc. Benjamin Chiarelli Benjamin Chiarelli CEO 2019-07-01